荣泰健康：9月29日召开董事会会议

Group 1 - Rongtai Health (SH 603579) held its 24th meeting of the 4th Board of Directors on September 29, 2025, in Shanghai, where it reviewed the proposal to amend the "Audit Committee Work Regulations" [1] - For the year 2024, Rongtai Health's revenue composition is as follows: manufacturing accounts for 98.32%, other businesses for 1.37%, and services for 0.31% [1] - As of the report date, Rongtai Health has a market capitalization of 7.2 billion yuan [1] Group 2 - The competition between Nongfu Spring and Yibao has intensified, with Nongfu Spring's green bottle launch leading to a significant decline in Yibao's market share, dropping nearly 5 percentage points [1]